LEGACY IS LOOKING FOR PARTICIPANTS

PAID CLINICAL TRIAL

• Lasting up to 6 months

• 3 Clinic Visits

YOU MAY BE ELIGIBLE TO PARTICIPATE IF YOU MEET THE FOLLOWING CRITERIA:​

• 60 years of age and older

Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that infects the lungs, but can also affect the nose and throat. RSV spreads in the fall and winter along with other respiratory viruses, like flu and COVID-19. RSV symptoms make it difficult to distinguish it from the common cold or other respiratory viruses (like the flu or COVID-19). Most people that get RSV will only have mild illness, but it can be very dangerous for babies, young children and adults 60 and older.  

​

PURPOSE OF STUDY:

The purpose of this clinical research study is to investigate a potential combination vaccine for the protection against respiratory disease caused by Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV).

​

​

​

​